Region Hovedstaden

Medicin og biovidenskab

1. Denmark 100%
2. Cohort Studies 70%
3. Therapeutics 58%
4. Systematic Reviews 55%
5. Randomized Controlled Trials 53%
6. Population 53%
7. Mortality 50%
8. Child 42%
9. Neoplasms 41%
10. Confidence Intervals 40%
11. Meta-Analysis 40%
12. Type 2 Diabetes Mellitus 39%
13. Exercise 34%
14. Placebos 32%
15. Registries 31%
16. Incidence 30%
17. Biomarkers 29%
18. Type 1 Diabetes Mellitus 29%
19. Genes 26%
20. Guidelines 26%
21. Survival 26%
22. Glucose 25%
23. Pregnancy 25%
24. Quality of Life 24%
25. Prospective Studies 24%
26. Heart Failure 23%
27. Pain 22%
28. Schizophrenia 22%
29. Odds Ratio 22%
30. Stroke 22%
31. Health 22%
32. Mutation 22%
33. Breast Neoplasms 21%
34. HIV 21%
35. Brain 21%
36. Myocardial Infarction 20%
37. Rheumatoid Arthritis 20%
38. Magnetic Resonance Imaging 20%
39. Muscles 20%
40. Safety 19%
41. Atrial Fibrillation 19%
42. Insulin 19%
43. Infections 19%
44. Asthma 19%
45. Cardiovascular Diseases 19%
46. Pharmaceutical Preparations 19%
47. Serum 18%
48. Migraine Disorders 18%
49. Observational Studies 18%
50. Inflammation 18%
51. Chronic Obstructive Pulmonary Disease 18%
52. Wounds and Injuries 17%
53. Depression 17%
54. Multiple Sclerosis 17%
55. Lung 17%
56. Obesity 17%
57. Parturition 16%
58. Body Mass Index 16%
59. Cross-Sectional Studies 16%
60. Recurrence 16%
61. Mothers 16%
62. Blood Pressure 16%
63. Databases 16%
64. Pediatrics 15%
65. Bipolar Disorder 15%
66. Kidney 15%
67. Skin 15%
68. Proteins 15%
69. Morbidity 15%
70. Delivery of Health Care 15%
71. Multicenter Studies 14%
72. Hip 14%
73. Phenotype 14%
74. Out-of-Hospital Cardiac Arrest 13%
75. Clinical Trials 13%
76. Comorbidity 13%
77. Smoking 13%
78. Hormones 13%
79. Genotype 13%
80. Hospitalization 13%
81. Healthy Volunteers 13%
82. Prostatic Neoplasms 13%
83. Skeletal Muscle 12%
84. Inflammatory Bowel Diseases 12%
85. Single Nucleotide Polymorphism 12%
86. Education 12%
87. Liver 12%
88. Colorectal Neoplasms 12%
89. Genome-Wide Association Study 12%
90. Patient Reported Outcome Measures 12%
91. Hypersensitivity 12%
92. Positron-Emission Tomography 12%
93. T-Lymphocytes 12%
94. Glucagon-Like Peptide 1 12%
95. Rehabilitation 11%
96. Drug Therapy 11%
97. Fats 11%
98. Elderly 11%
99. Psoriasis 11%
100. Ovarian Neoplasms 11%